Browse by Title

Type here to filter the list

D
DAPT Choice and Duration in Patients with AF on Anticoagulants

Michael J. Rinaldi, MD – Sanger Heart and Vascular Institute/Atrium Health ### 171411###Speaker###Director Structural Heart Program###Sanger Heart and Vascular Institute/Atrium Health###
Speaker: Michael J. Rinaldi, MD – Sanger Heart and Vascular Institute/Atrium Health
###
Day 1: Wires, Crossing Catheters, Sheaths, and Closure

George Adams, MD (he/him/his) – Cordis ### 1560820###Facilitator###Chief Medical Officer, Cordis###Cordis###
Facilitator: George Adams, MD (he/him/his) – Cordis
### he/him/his @@@ Mohammad M. Ansari, MD – Texas Tech University Health Sciences Center ### 320261###Facilitator###Assistant Professor/ Cath Lab Director###Texas Tech University Health Sciences Center###
Facilitator: Mohammad M. Ansari, MD – Texas Tech University Health Sciences Center
### @@@ Nelson L. Bernardo, MD, FSCAI (he/him/his) – MedStar Heart and Vascular Institute at MedStar Washington Hospital Center ### 163026###Facilitator###Medical Director###MedStar Heart and Vascular Institute at MedStar Washington Hospital Center###
Facilitator: Nelson L. Bernardo, MD, FSCAI (he/him/his) – MedStar Heart and Vascular Institute at MedStar Washington Hospital Center
### he/him/his @@@ Eric J. Dippel, MD – Vascular Institute of the Midwest, PC ### 163085###Facilitator###Interventional Cardiologist###Vascular Institute of the Midwest, PC###
Facilitator: Eric J. Dippel, MD – Vascular Institute of the Midwest, PC
### @@@ Jihad A. Mustapha, MD, FACC, FSCAI (he/him/his) – Advanced Cardiac & Vascular Centers for Amputation Prevention ### 163223###Facilitator###CEO###Advanced Cardiac & Vascular Centers for Amputation Prevention###
Facilitator: Jihad A. Mustapha, MD, FACC, FSCAI (he/him/his) – Advanced Cardiac & Vascular Centers for Amputation Prevention
### he/him/his @@@ James P. Zidar, MD, FSCAI – University of North Carolina/Rex Healthcare ### 163358###Facilitator###Clinical Professor of Medicine###University of North Carolina/Rex Healthcare###
Facilitator: James P. Zidar, MD, FSCAI – University of North Carolina/Rex Healthcare
###
Day 1: Wires, Crossing Catheters, Sheaths, and Closure. This session will be divided in two parts with an emphasis on practical hands-on instruction augmented by expert guidance. Part 1: Focus on strategic use of guidewires, crossing catheters, sheaths, and closure methods with an aim to match devices and techniques to specific patient scenarios. Part 2: Radial-to-peripheral: How and when to use radial access for peripheral arterial intervention.
Day 2: Vessel prep, Balloons and Stents

George Adams, MD (he/him/his) – Cordis ### 1560820###Facilitator###Chief Medical Officer, Cordis###Cordis###
Facilitator: George Adams, MD (he/him/his) – Cordis
### he/him/his @@@ Eric J. Dippel, MD – Vascular Institute of the Midwest, PC ### 163085###Facilitator###Interventional Cardiologist###Vascular Institute of the Midwest, PC###
Facilitator: Eric J. Dippel, MD – Vascular Institute of the Midwest, PC
### @@@ Anahita Dua, MD MS MBA FACS – Harvard Medical School ### 488857###Facilitator###Associate Professor of Surgery###Harvard Medical School###
Facilitator: Anahita Dua, MD MS MBA FACS – Harvard Medical School
### @@@ William A. Gray, MD, FSCAI – Main Line Health ### 163121###Facilitator###System Chief of Cardiovascular Services, Main Line Health/President, Lankenau Heart Institute ###Main Line Health###
Facilitator: William A. Gray, MD, FSCAI – Main Line Health
### @@@ Jihad A. Mustapha, MD, FACC, FSCAI (he/him/his) – Advanced Cardiac & Vascular Centers for Amputation Prevention ### 163223###Facilitator###CEO###Advanced Cardiac & Vascular Centers for Amputation Prevention###
Facilitator: Jihad A. Mustapha, MD, FACC, FSCAI (he/him/his) – Advanced Cardiac & Vascular Centers for Amputation Prevention
### he/him/his @@@ Eric A. Secemsky, MD, MSc – Beth Israel Deaconess Medical Center ### 653443###Facilitator###Director of Vascular Intervention###Beth Israel Deaconess Medical Center###
Facilitator: Eric A. Secemsky, MD, MSc – Beth Israel Deaconess Medical Center
### @@@ Peter A. Soukas, MD, FSCAI – Cardiovascular Institute/ Brown Medical School ### 171169###Facilitator###Director, Vascular Medicine & Interventional PV Lab###Cardiovascular Institute/ Brown Medical School###
Facilitator: Peter A. Soukas, MD, FSCAI – Cardiovascular Institute/ Brown Medical School
###
Day 2: Vessel prep, Balloons and Stents. This session will focus on vessel prep using a wide variety of devices which will include – Atherectomy, Thrombectomy, and Intravascular Lithotripsy. Emphasis on device selection and technique. Vessel prep will be tied to lesion treatment with an additional session on the use of balloon angioplasty, and stenting.
DCB for Complex Coronary Lesions

Antonio Colombo, MD – Humanitas IRCCS ### 163064###Speaker###Professor of Cardiology###Humanitas IRCCS###
Speaker: Antonio Colombo, MD – Humanitas IRCCS
###
DCB for Coronary – FDA Perspective

Tara A. Ryan, MD, MS, MBA – FDA ### 328175###Speaker###Medical Officer###FDA###
Speaker: Tara A. Ryan, MD, MS, MBA – FDA
###
DCB FOR CORONARY AND PERIPHERAL APPLICATIONS

J. Dawn Abbott, MD – Brown University ### 465924###Moderator###Director, Interventional Cardiology at the Lifespan Cardiovascular Institute Director, Cardiac Catheterization Laboratories at Rhode Island and The Miriam Associate Chief, Faculty Development and Academic Advancement Professor of Medicine ,Warren Alpert Medical School, Brown University ###Brown University###
Moderator: J. Dawn Abbott, MD – Brown University
### @@@ Dean J. Kereiakes, MD, FACC, MSCAI – The Christ Hospital Health Network ### 163163###Moderator###President, The Christ Hospital Heart and Vascular Institute; Medical Director, The Christ Hospital Research Institute; Professor of Clinical Medicine, The Ohio State University###The Christ Hospital Health Network###
Moderator: Dean J. Kereiakes, MD, FACC, MSCAI – The Christ Hospital Health Network
### @@@ Bruno Scheller, MD – University of Saarland ### 163284###Moderator###Professor of Clinical and Experimental Interventional Cardiology###University of Saarland###
Moderator: Bruno Scheller, MD – University of Saarland
### @@@ Gunnar Tepe, MD – Hospital of Rosenhein ### 163311###Moderator###Head of Department of Diagnostic and Interventional Radiology###Hospital of Rosenhein###
Moderator: Gunnar Tepe, MD – Hospital of Rosenhein
###
DCB in CAD: Expanding the Indications of Use

Antonio Colombo, MD – Humanitas IRCCS ### 163064###Speaker###Professor of Cardiology###Humanitas IRCCS###
Speaker: Antonio Colombo, MD – Humanitas IRCCS
###
DCB vs. POBA Versus Stent BTK – Is There any Hope for Devices Below the Knee

Jihad A. Mustapha, MD, FACC, FSCAI (he/him/his) – Advanced Cardiac & Vascular Centers for Amputation Prevention ### 163223###Speaker###CEO###Advanced Cardiac & Vascular Centers for Amputation Prevention###
Speaker: Jihad A. Mustapha, MD, FACC, FSCAI (he/him/his) – Advanced Cardiac & Vascular Centers for Amputation Prevention
### he/him/his
DCBs" Sirolimus, PTX, or Something Else?

Aloke V. Finn, MD – CVPath ### 181604###Speaker###Medical Director CVPath/Assoc. Prof. Of Medicine University of Maryland###CVPath###
Speaker: Aloke V. Finn, MD – CVPath
###
Debate: My Patient has a Blood Pressure of 150/90 Despite 2 Maximally Dosed Medications – Time for

Judith Veis, MD – Medstar Washington Hospital Center ### 188316###Speaker###Section Director, Nephrology###Medstar Washington Hospital Center###
Speaker: Judith Veis, MD – Medstar Washington Hospital Center
###
Debate: My Patient has a Blood Pressure of 150/90 Despite 2 Maximally Dosed Medications – Time for

Eric A. Secemsky, MD, MSc – Beth Israel Deaconess Medical Center ### 653443###Speaker###Director of Vascular Intervention###Beth Israel Deaconess Medical Center###
Speaker: Eric A. Secemsky, MD, MSc – Beth Israel Deaconess Medical Center
###
Deep Dive Into the Results of the SPYRAL Hypertension Program (OFF-MED and ON-MED Trials)

David E. Kandzari, MD, FACC, FSCAI – Piedmont Heart Institute ### 163153###Speaker###Director, Interventional Cardiology, Piedmont Heart Institute; Chief Scientific Officer, Piedmont Healthcare###Piedmont Heart Institute###
Speaker: David E. Kandzari, MD, FACC, FSCAI – Piedmont Heart Institute
###
Definitive CTO PCI to Left Circumflex Artery After STEMI PCI to Vein Graft Lesion

Kalyan Chitturi, DO – University of Missouri, Columbia ### 1872216###Speaker###Fellow###University of Missouri, Columbia###
Speaker: Kalyan Chitturi, DO – University of Missouri, Columbia
###
Delayed Coronary Obstruction due to Sinus Sequestration After Transcatheter Supra-Annular Valve Implantation

Pier Pasquale Leone, MD – Montefiore Medical Center ### 1545028###Speaker###Visiting Cardiology Fellow ###Montefiore Medical Center###
Speaker: Pier Pasquale Leone, MD – Montefiore Medical Center
###
Delayed Coronary Obstruction Due to Sinus Sequestration After Transcatheter Supra-Annular Valve Implantation

Pier Pasquale Leone, MD – Montefiore Medical Center ### 1545028###Speaker###Visiting Cardiology Fellow ###Montefiore Medical Center###
Speaker: Pier Pasquale Leone, MD – Montefiore Medical Center
###
Delaying Reperfusion Plus Lv Unloading Reduces Infarct Size: A Per-protocol-analysis Of The Stemi-dtu Pilot Study

Mohit Pahuja, MD – University of Oklahoma Medical Center ### 1519862###Speaker###Assistant Professor of Medicine, Division of Interventional and advanced heart failure cardiology###University of Oklahoma Medical Center###
Speaker: Mohit Pahuja, MD – University of Oklahoma Medical Center
###
Delete Talk
Designated Devices for AI treatment: Industry Perspective

Duane Pinto, MD, MPH, FSCAI – JenaValve ### 163247###Speaker###Chief Medical Officer###JenaValve###
Speaker: Duane Pinto, MD, MPH, FSCAI – JenaValve
###
Designing a Clinical Trial for Severe AI in Moderate and Low Risk Patients: Is it Feasible?

Michael J. Reardon, MD – Houston Methodist DeBakey Heart & Vascular Center ### 163255###Speaker###Professor and Allison Family Distinguished Chair of Cardiovascular Research###Houston Methodist DeBakey Heart & Vascular Center###
Speaker: Michael J. Reardon, MD – Houston Methodist DeBakey Heart & Vascular Center
###
Detection of Vulnerable Plaques by CT Angiography

James A. Goldstein, MD, FSCAI – Beaumont Health System ### 163116###Speaker###Director, Research and Education###Beaumont Health System###
Speaker: James A. Goldstein, MD, FSCAI – Beaumont Health System
###
Development of Pediatric Medical Devices by Academia-industry-Government Collaboration in Japan - More than Cooperation

Shintaro Nemoto, MD, Ph.D – Osaka Medical and Pharmaceutical University ### 1876477###Speaker###Professor###Osaka Medical and Pharmaceutical University###
Speaker: Shintaro Nemoto, MD, Ph.D – Osaka Medical and Pharmaceutical University
###
Device Based Therapies: Where do we Stand?

Vasilios Papademetriou, MD, DSc – Georgetown University/VAMC ### 188312###Speaker###Director Interventional Hypertension and Vascular Medicine###Georgetown University/VAMC###
Speaker: Vasilios Papademetriou, MD, DSc – Georgetown University/VAMC
###
Device Combinations: ECMO Plus IMPELLA or IABP: A User’s Guide

Holger Thiele, MD – Heart Center Leipzig ### 596071###Speaker###Head of department###Heart Center Leipzig###
Speaker: Holger Thiele, MD – Heart Center Leipzig
###
DEVICE SELECTION FOR CARDIOGENIC SHOCK: A DEEP DIVE TO MULTIPLE OPTIONS

Babar Basir, DO – Henry Ford Hospital ### 657365###Moderator###Directory of Acute Mechanical Circulatory Support###Henry Ford Hospital ###
Moderator: Babar Basir, DO – Henry Ford Hospital
### @@@ Katherine Kunkel, MD – Piedmont Heart Institute ### 947276###Moderator###Interventional Cardiologist###Piedmont Heart Institute###
Moderator: Katherine Kunkel, MD – Piedmont Heart Institute
###
Device Selection for TEER Clip - What Type for individual Pathologies

Bruce J. Rutkin, MD (he/him/his) – Northwell Health ### 272754###Speaker###Director of Structural Heart Disease###Northwell Health###
Speaker: Bruce J. Rutkin, MD (he/him/his) – Northwell Health
### he/him/his
Device-Base Therapies for Heart Failure in the Modern Era: Innovation in Heart Failure Trial Designs

Ori Ben-Yehuda, MD (he/him/his) – University of California, San Diego ### 163024###Speaker###Professor of Medicine###University of California, San Diego###
Speaker: Ori Ben-Yehuda, MD (he/him/his) – University of California, San Diego
### he/him/his
DEVICES TO PREVENT CORONARY OBSTRUCTION AND ENABLERS OF LIVE MANAGEMENT

Robert J. Lederman, MD – National Institutes of Health/National Heart, Lung, and Blood Institute ### 163184###Moderator###Senior Investigator, Chief, Laboratory of Cardiovascular Intervention###National Institutes of Health/National Heart, Lung, and Blood Institute###
Moderator: Robert J. Lederman, MD – National Institutes of Health/National Heart, Lung, and Blood Institute
### @@@ Toby Rogers, MD, PhD – Georgetown University and MedStar Washington Hospital Center ### 185869###Moderator###Associate Professor of Medicine (Cardiology) and Scientific Lead for Structural Heart Disease###Georgetown University and MedStar Washington Hospital Center###
Moderator: Toby Rogers, MD, PhD – Georgetown University and MedStar Washington Hospital Center
###
Diagnosis of Plaque Erosion

Fernando Alfonso, MD – Hospital Univeritario La Princesa, Madrid ### 1835483###Speaker###Head, Department of Cardiology###Hospital Univeritario La Princesa, Madrid###
Speaker: Fernando Alfonso, MD – Hospital Univeritario La Princesa, Madrid
###
Dib UltraNav Transseptal Catheter System

Nabil Dib, MD, MSc, FACC – Mercy Gilbert Medical Center/Dignity Health ### 939332###Speaker###Director Cardiovascular Research###Mercy Gilbert Medical Center/Dignity Health###
Speaker: Nabil Dib, MD, MSc, FACC – Mercy Gilbert Medical Center/Dignity Health
###
Dietary and Pharmacologic Approaches to Hypertension Management in 2023 – What’s New and What’s Changed

Kim Allan Williams, Sr., MD, MACC, FAHA, MASNC, FESC – University of Louisville ### 302894###Speaker###Chair, Department of Medicine###University of Louisville###
Speaker: Kim Allan Williams, Sr., MD, MACC, FAHA, MASNC, FESC – University of Louisville
###
Differences in Atherosclerosis in Different Beds

Renu Virmani, MD – CVPath Institute, Inc. ### 163332###Speaker###President###CVPath Institute, Inc.###
Speaker: Renu Virmani, MD – CVPath Institute, Inc.
###
Difficult LAA: Tips/Tricks to Close with WATCHMAN

Srinivas Iyengar, MD – Boulder Heart at Anderson Medical Center (Boulder Community Health) ### 1526119###Speaker###Director, Structural Heart###Boulder Heart at Anderson Medical Center (Boulder Community Health)###
Speaker: Srinivas Iyengar, MD – Boulder Heart at Anderson Medical Center (Boulder Community Health)
###
DIGITAL HEALTH AND ARTIFICIAL INTELLIGENCE

Fumiaki Ikeno, MD – Stanford University ### 163144###Moderator###Researcher###Stanford University###
Moderator: Fumiaki Ikeno, MD – Stanford University
### @@@ Madoka Murakami, PhD – Ministry of Health, Labour and Welfare, Japan ### 193499###Moderator###Deputy Director###Ministry of Health, Labour and Welfare, Japan###
Moderator: Madoka Murakami, PhD – Ministry of Health, Labour and Welfare, Japan
###
Digital Health in Preventive Cardiology

Seth S. Martin, MD, MHS, FACC, FAHA, FASPC – Johns Hopkins ### 316907###Speaker###Associate Professor###Johns Hopkins###
Speaker: Seth S. Martin, MD, MHS, FACC, FAHA, FASPC – Johns Hopkins
###
Dinner
Dinner
Dinner
Dinner
Dinner
Dinner
Discussion and Questions

S. Jay Mathews, MD – Manatee Memorial Hospital ### 1432175###Panel Moderator###Director, Cardiac Cath Lab, PERT, & Structural Heart###Manatee Memorial Hospital###
Panel Moderator: S. Jay Mathews, MD – Manatee Memorial Hospital
### @@@ Hayder D. Hashim, MD – Medstar Washington Hospital Center/Georgetown University ### 672368###Panel Discussant###Interventional Cardiologist###Medstar Washington Hospital Center/Georgetown University ###
Panel Discussant: Hayder D. Hashim, MD – Medstar Washington Hospital Center/Georgetown University
### @@@ Elias Iliadis, MD (he/him/his) – Cooper university Healthcare ### 1899088###Panel Discussant###Program Director, interventional Cardiology Fellowship###Cooper university Healthcare###
Panel Discussant: Elias Iliadis, MD (he/him/his) – Cooper university Healthcare
### he/him/his
Discussion and Wrap-Up
Discussion: Is there a Role/Need for Bioresorbable and/or Bioadaptor Platforms?

Alexandre A. Abizaid, MD, PhD – Incor ### 162997###Panel Moderator###Director of Invasive Cardiology###Incor###
Panel Moderator: Alexandre A. Abizaid, MD, PhD – Incor
### @@@ Ricardo A. Costa, MD, PhD – Institute Dante Pazzanese of Cardiology ### 163067###Panel Moderator###Interventional Cardiologist - Percutaneous Intervention Research Medical Section Chief###Institute Dante Pazzanese of Cardiology###
Panel Moderator: Ricardo A. Costa, MD, PhD – Institute Dante Pazzanese of Cardiology
### @@@ Yoshinobu Onuma, MD, PhD (he/him/his) – National University of Ireland, Galway ### 163238###Panel Moderator###Professor of Interventional Cardiology###National University of Ireland, Galway###
Panel Moderator: Yoshinobu Onuma, MD, PhD (he/him/his) – National University of Ireland, Galway
### he/him/his @@@ Michael H. Joner, MD – Deutsches Herzzentrum Muenchen ### 163150###Panel Moderator###Associate Professor Interventional Cardiology###Deutsches Herzzentrum Muenchen###
Panel Moderator: Michael H. Joner, MD – Deutsches Herzzentrum Muenchen
### @@@ Robert A. Byrne, MD, BCh, PhD – Mater Private Hospital, RCSI University of Medicine and Health Sciences, Dublin, Ireland ### 163048###Panel Discussant###Director of Cardiology### Mater Private Hospital, RCSI University of Medicine and Health Sciences, Dublin, Ireland###
Panel Discussant: Robert A. Byrne, MD, BCh, PhD – Mater Private Hospital, RCSI University of Medicine and Health Sciences, Dublin, Ireland
### @@@ Haim Danenberg, MD – Wolfson Medical Center ### 163073###Panel Discussant###Head of interventional cardiology###Wolfson Medical Center###
Panel Discussant: Haim Danenberg, MD – Wolfson Medical Center
### @@@ David Erlinge, MD, PhD (he/him/his) – Lund University ### 1213219###Panel Discussant###Professor, Consultant Interventional Cardiology###Lund University###
Panel Discussant: David Erlinge, MD, PhD (he/him/his) – Lund University
### he/him/his @@@ Hector M. Garcia-Garcia, MD, PhD – MedStar Washington Hospital Center ### 163109###Panel Discussant###Director of Invasive Imaging Core Laboratory###MedStar Washington Hospital Center###
Panel Discussant: Hector M. Garcia-Garcia, MD, PhD – MedStar Washington Hospital Center
### @@@ Michael Haude, MD, PhD – Rheinland Klinikum Neuss GmbH ### 185856###Panel Discussant###Director of the Heart & Vascular Center###Rheinland Klinikum Neuss GmbH###
Panel Discussant: Michael Haude, MD, PhD – Rheinland Klinikum Neuss GmbH
### @@@ Dean J. Kereiakes, MD, FACC, MSCAI – The Christ Hospital Health Network ### 163163###Panel Discussant###President, The Christ Hospital Heart and Vascular Institute; Medical Director, The Christ Hospital Research Institute; Professor of Clinical Medicine, The Ohio State University###The Christ Hospital Health Network###
Panel Discussant: Dean J. Kereiakes, MD, FACC, MSCAI – The Christ Hospital Health Network
### @@@ Sahil A. Parikh, MD, FSCAI – Columbia University Vagelos College of Physicians and Surgeons ### 163242###Panel Discussant###Associate Professor of Medicine###Columbia University Vagelos College of Physicians and Surgeons###
Panel Discussant: Sahil A. Parikh, MD, FSCAI – Columbia University Vagelos College of Physicians and Surgeons
### @@@ Eline H. Ploumen, MD, PhD (she/her/hers) – Thoraxcentrum Twente ### 1528065###Panel Discussant###Cardiology resident###Thoraxcentrum Twente###
Panel Discussant: Eline H. Ploumen, MD, PhD (she/her/hers) – Thoraxcentrum Twente
### she/her/hers @@@ Richard J. Rapoza, PhD – Abbott Vascular ### 163254###Panel Discussant###Divisional Vice President, Global Research and Development###Abbott Vascular###
Panel Discussant: Richard J. Rapoza, PhD – Abbott Vascular
### @@@ Pieter C. Smits, PhD, FESC – Maasstad Ziekenhuis ### 242821###Panel Discussant###Director Interventional Cardiology###Maasstad Ziekenhuis###
Panel Discussant: Pieter C. Smits, PhD, FESC – Maasstad Ziekenhuis
### @@@ Robert-Jan M. van Geuns, MD, PhD (he/him/his) – RadboudUMC ### 340225###Panel Discussant###Cardiologist###RadboudUMC###
Panel Discussant: Robert-Jan M. van Geuns, MD, PhD (he/him/his) – RadboudUMC
### he/him/his
Discussion Panel: How Could Prospective International Registry Data Help Industry Most?

Misti Malone, PhD (she/her/hers) – FDA ### 201905###Panel Moderator###Asst Director, PIDT###FDA###
Panel Moderator: Misti Malone, PhD (she/her/hers) – FDA
### she/her/hers @@@ Mami Ho, MD, PhD – Pharmacueticals and Medical Devices Agency(PMDA) ### 193496###Panel Moderator###Senior Scientist for Clinical Medicione###Pharmacueticals and Medical Devices Agency(PMDA)###
Panel Moderator: Mami Ho, MD, PhD – Pharmacueticals and Medical Devices Agency(PMDA)
### @@@ Nina Deno, PhD ### 1886920###Panel Discussant#########
Panel Discussant: Nina Deno, PhD
### @@@ Elisa Hebb ### 1887102###Panel Discussant#########
Panel Discussant: Elisa Hebb
### @@@ Melanie Raska ### 1859190###Panel Discussant#########
Panel Discussant: Melanie Raska
### @@@ Josh Smale ### 1886688###Panel Discussant#########
Panel Discussant: Josh Smale
### @@@ Poornima Sood, MD ### 1887025###Panel Discussant#########
Panel Discussant: Poornima Sood, MD
### @@@ Kartik Sundareswaran, PhD ### 1887204###Panel Discussant#########
Panel Discussant: Kartik Sundareswaran, PhD
###
Discussion Panel: What Could International Registry/ARO/CRO Collaborations with Industry for EU MDR Submissions look Like?

Mami Ho, MD, PhD – Pharmacueticals and Medical Devices Agency(PMDA) ### 193496###Panel Moderator###Senior Scientist for Clinical Medicione###Pharmacueticals and Medical Devices Agency(PMDA)###
Panel Moderator: Mami Ho, MD, PhD – Pharmacueticals and Medical Devices Agency(PMDA)
### @@@ Misti Malone, PhD (she/her/hers) – FDA ### 201905###Panel Moderator###Asst Director, PIDT###FDA###
Panel Moderator: Misti Malone, PhD (she/her/hers) – FDA
### she/her/hers @@@ David Erlinge, MD, PhD (he/him/his) – Lund University ### 1213219###Panel Discussant###Professor, Consultant Interventional Cardiology###Lund University###
Panel Discussant: David Erlinge, MD, PhD (he/him/his) – Lund University
### he/him/his @@@ C. Michael Gibson, MD – Beth Israel Deaconess Medical Center ### 163112###Panel Discussant###Professor of Medicine###Beth Israel Deaconess Medical Center###
Panel Discussant: C. Michael Gibson, MD – Beth Israel Deaconess Medical Center
### @@@ Mitchell Krucoff, MD, FACC (he/him/his) – Duke University Medical Center/Duke Clinical Research Institute ### 163174###Panel Discussant###Professor Medicine/Cardiology###Duke University Medical Center/Duke Clinical Research Institute###
Panel Discussant: Mitchell Krucoff, MD, FACC (he/him/his) – Duke University Medical Center/Duke Clinical Research Institute
### he/him/his @@@ Ernest Spitzer, MD – Cardialysis B.V. ### 1299623###Panel Discussant###Chief Medical Officer###Cardialysis B.V.###
Panel Discussant: Ernest Spitzer, MD – Cardialysis B.V.
### @@@ Holger Thiele, MD – Heart Center Leipzig ### 596071###Panel Discussant###Head of department###Heart Center Leipzig###
Panel Discussant: Holger Thiele, MD – Heart Center Leipzig
### @@@ Fran Thorpe, DrPH ### 1887820###Panel Discussant#########
Panel Discussant: Fran Thorpe, DrPH
###
Discussion Summaries and Final Thoughts
DISPARITIES IN CLINICAL TRIALS AND BEYOND

Joaquin E. Cigarroa, MD – OHSU Knight Cardiovascular Institute ### 914907###Moderator###Head of the Division of Cardiovascular Medicine###OHSU Knight Cardiovascular Institute###
Moderator: Joaquin E. Cigarroa, MD – OHSU Knight Cardiovascular Institute
### @@@ Rebecca Torguson, MPH – FDA ### 163318###Moderator###Deputy Division Director###FDA###
Moderator: Rebecca Torguson, MPH – FDA
### @@@ Karol Watson, MD, PhD – Ronald Reagan UCLA Medical Center ### 457694###Moderator###Attending Cardiologist###Ronald Reagan UCLA Medical Center###
Moderator: Karol Watson, MD, PhD – Ronald Reagan UCLA Medical Center
### @@@ Kim Allan Williams, Sr., MD, MACC, FAHA, MASNC, FESC – University of Louisville ### 302894###Moderator###Chair, Department of Medicine###University of Louisville###
Moderator: Kim Allan Williams, Sr., MD, MACC, FAHA, MASNC, FESC – University of Louisville
###
DISPARITIES: INEQUALITIES IN INTERVENTIONAL CARDIOLOGY AND HEALTHCARE

Wayne Batchelor, MD, MHS – Inova Heart & Vascular Institute ### 457703###Moderator###Director, Interventional Cardiology and Interventional Research and Innovation###Inova Heart & Vascular Institute###
Moderator: Wayne Batchelor, MD, MHS – Inova Heart & Vascular Institute
### @@@ Sara D. Collins, MD (she/her/hers) – Chesapeake Cardiac Care ### 163062###Moderator###Attending Physician###Chesapeake Cardiac Care###
Moderator: Sara D. Collins, MD (she/her/hers) – Chesapeake Cardiac Care
### she/her/hers @@@ Aaron Horne, Jr., MD, MBA – Summit Health ### 457690###Moderator###Structural Interventionalist###Summit Health###
Moderator: Aaron Horne, Jr., MD, MBA – Summit Health
### @@@ Spencer B. King, III, MD, MACC, MSCAI – Emory University ### 163166###Moderator###Professor of Medicine Emeritus###Emory University###
Moderator: Spencer B. King, III, MD, MACC, MSCAI – Emory University
###
Disruption of Angioplasty Balloon During Percutaneous Coronary Intervention

Mario Sadaba, MD – Hospital de Galdakao ### 320270###Speaker###Interventional cardiologist###Hospital de Galdakao###
Speaker: Mario Sadaba, MD – Hospital de Galdakao
###
Donor Vessel Injury

Rajan Patel, MD (he/him/his) – Ochsner Medical Center, Ochsner Clinical School, Univ. of Queensland ### 485076###Speaker###Interventional Cardiology Fellowship Program Director & Medical Director CTO PCI program###Ochsner Medical Center, Ochsner Clinical School, Univ. of Queensland###
Speaker: Rajan Patel, MD (he/him/his) – Ochsner Medical Center, Ochsner Clinical School, Univ. of Queensland
### he/him/his
Doppio Intravascular Lithotripsy-Facilitated Transfemoral TAVR Through Severely Calcified Aortic Carrefour

Pier Pasquale Leone, MD – Montefiore Medical Center ### 1545028###Speaker###Visiting Cardiology Fellow ###Montefiore Medical Center###
Speaker: Pier Pasquale Leone, MD – Montefiore Medical Center
###
Doppler and Thermodilution Measured Flow are Not the Same but Close

Javier Escaned, MD, PhD (he/him/his) – Hospital Clínico San Carlos ### 184736###Speaker###Head of Section (Interventional Cardiology) / Dept. of Cardiology###Hospital Clínico San Carlos###
Speaker: Javier Escaned, MD, PhD (he/him/his) – Hospital Clínico San Carlos
### he/him/his
Dorsal 'Snuff Box' Radial Access: Back Door to the Arterial System

Ian C. Gilchrist, Sr., MD, MSCAI (he/him/his) – Penn State University/Hershey Medical Center ### 163113###Speaker###Professor Of Medicine###Penn State University/Hershey Medical Center###
Speaker: Ian C. Gilchrist, Sr., MD, MSCAI (he/him/his) – Penn State University/Hershey Medical Center
### he/him/his
Double-Lumen Catheter to Facilitate Atrial Septal Procedures and the Transseptal Delivery of Catheters – Dib UltraNav Transseptal Catheter System

Nabil Dib, MD, MSc, FACC – Mercy Gilbert Medical Center/Dignity Health ### 939332###Speaker###Director Cardiovascular Research###Mercy Gilbert Medical Center/Dignity Health###
Speaker: Nabil Dib, MD, MSc, FACC – Mercy Gilbert Medical Center/Dignity Health
###
Driving Innovation Today and Beyond: Lessons Learned

Mark A. Turco, MD – Cardiac Implants ### 163321###Speaker###CEO###Cardiac Implants###
Speaker: Mark A. Turco, MD – Cardiac Implants
###
Drug Coated Balloons Versus Drug Eluting Stents In Patients Undergoing Primary Percutaneous Coronary Intervention In ST Elevation Myocardial Infarction: A Meta-analysis Of Randomized Trials

Khagendra Dahal, MD – Creighton/CHI ### 431850###Speaker###Assistant Professor###Creighton/CHI ###
Speaker: Khagendra Dahal, MD – Creighton/CHI
###
Drug Elution for PAD: Highlights and Innovations

Sahil A. Parikh, MD, FSCAI – Columbia University Vagelos College of Physicians and Surgeons ### 163242###Speaker###Associate Professor of Medicine###Columbia University Vagelos College of Physicians and Surgeons###
Speaker: Sahil A. Parikh, MD, FSCAI – Columbia University Vagelos College of Physicians and Surgeons
###
Drug-eluting Stent Versus Bare Metal Stents For Femoropopliteal Peripheral Artery Disease: Asystematic Review And Meta-analysi

Waiel Abusnina, MD (he/him/his) – Creighton University ### 1545033###Speaker###General Cardiology Fellow###Creighton University###
Speaker: Waiel Abusnina, MD (he/him/his) – Creighton University
### he/him/his
Dual WATCHMAN for Complex Left Atrial Appendage

Muhammad Siddique Pir, MD (he/him/his) – The Wright Center for Graduate Medical Education ### 1872230###Speaker###Cardiology Fellow###The Wright Center for Graduate Medical Education###
Speaker: Muhammad Siddique Pir, MD (he/him/his) – The Wright Center for Graduate Medical Education
### he/him/his
DurAVR™ Transcatheter Heart Valve: First In Human Clinical Update

Michael J. Reardon, MD – Houston Methodist DeBakey Heart & Vascular Center ### 163255###Speaker###Professor and Allison Family Distinguished Chair of Cardiovascular Research###Houston Methodist DeBakey Heart & Vascular Center###
Speaker: Michael J. Reardon, MD – Houston Methodist DeBakey Heart & Vascular Center
###
DynamX Bioadaptor: Novel Coronary Prosthesis Enters IDE Trial

David Erlinge, MD, PhD (he/him/his) – Lund University ### 1213219###Speaker###Professor, Consultant Interventional Cardiology###Lund University###
Speaker: David Erlinge, MD, PhD (he/him/his) – Lund University
### he/him/his